Among these genomic alterations, BRCA1 and BRCA2—genes traditionally associated with breast and ovarian cancers—are emerging as key players in OSCC due to their roles in maintaining genomic stability and regulating DNA damage repair. This evidence concerns the gene BRCA2 and ovarian carcinoma.